Abstract: Red cell distribution width (RDW) is an indicator for the variability and size of circulating erythrocytes. Although some recent studies indicate that RDW can be used as a prognostic indicator in the management of patients with ST elevation myocardial infarction, several additional studies will be required to come on to agreement for its routine use. The study was an institution based observational cohort study that took place from May 1, 2013 to April 30 2014 at the First Affiliated Hospital of Zhengzhou University. Sixty patients with ST elevation myocardial infarction undergoing percutaneous coronary intervention were included in the study by convenient method. The Patients were divided in to two groups according to the RDW: 30(50%) patients with high RDW (range: ≥14%), and the rest 30(50%) patients with normal RDW (range: 11-13.9%). ST elevation Myocardial infarction is designated as an increase in troponin and CK-MB and ECG ST elevation. The demographic characteristics and parameters were included from patient records and severity of CAD was determined from angiography result. Complete blood count was done to measure level of red cell distribution width. Major adverse cardiac events (MACE) occur in 6 (20%) patients of High RDW group. High RDW is correlated with both higher MACE (r=0.333; p=0.009) as compared to patients with normal RDW. In Kaplan Meier analysis normal RDW patients had better survival than high RDW patients with higher GRACE score (r=0.293; p=0.024). Moreover absolute high RDW was correlated with both higher GRACE score (r=0.510; p=0.000) and with high MACE (r=0.427; p=0.001). Higher RDW at baseline was strongly correlated with Major adverse cardiac events both in the hospital and one month follow up. RDW should be routinely used as a baseline test in the management of patients with ST elevation myocardial infarction undergoing percutaneous coronary intervention.
Original Research
accounted for 86% of the Global CVD disease burden. Globally, CVD deaths have been projected to increase from 16.7 million in 2002 to 23.2 million in 2030, with Ischemic Heart disease (IHD) and stroke among the four leading causes of death worldwide regardless of national economic status. This projected increase is explained by demographics. On one hand, population growth will have the highest impact in low and middle-income countries resulting in a significant increase in the absolute number of chronic diseases like IHD, despite the declining trend of age-specific death rates (3) .
Red cell distribution width (RDW) is an indicator for the variability and size of circulating erythrocytes. RDW is obtained routinely in standard complete blood cell counts without additional cost and alterations in RDW values are commonly used for differential diagnosis of anemia. Increased RDW indicates the presence of anisocytosis which is related to impaired erythropoiesis and erythrocyte degradation reflecting chronic inflammation and high level of oxidative stress. Although the underlying biological mechanisms remain unclear. On the other hand increase in RDW values has recently shown to be associated with heart failure, coronary artery disease and peripheral artery disease. The severity of atherosclerosis and inflammation are much related to each other. RDW is thought to be an indicator of inflammation, as increased value may be a consequence of oxidative stress on erythrocytes (4).
Introduction
Worldwide, coronary artery disease (CAD) is the single most frequent cause of death. Over seven million people every year die from CAD, accounting for 12.8% of all deaths. Every sixth man and every seventh woman in Europe will die from myocardial infarction. The incidence of hospital admissions for acute myocardial infarction (AMI) with ST-segment elevation myocardial infarction (STEMI) varies among countries that belong to the European Society of cardiology (1) .
Substantial improvements in the primary and secondary prevention of myocardial infarction (MI) have occurred over the previous 20 years, based on results from a number of landmark clinical trials. However, during the same period the US population has become less physically active, more obese, more often diabetic and older. Understanding the net effect of these disparate trends on the incidence of MI is of critical importance. At the most fundamental level, whether MIs are increasing or decreasing in incidence is the ultimate measure of the success or failure of the efforts of the public health, primary care and cardiology communities to prevent heart disease (2).
Cardiovascular disease (CVD) is advancing in the developing countries. For instance, some 80% of all CVD deaths worldwide in 2000 occurred in low and middle-income developing countries, while these countries also In recent years, studies have constantly shown that RDW is closely related to the prognosis and long-term adverse events of cardiovascular diseases. Felker et al first found in 2007 that increased RDW is an independent prognostic predictor for heart failure (5, 6) .
The aim of this study is to look for RDW as an important prognostic indicator in patients with ST elevation myocardial infarction who undergo Percutaneous Coronary Intervention (PCI).
Patients and methods

Study setting
The study took place in First Affiliated Hospital of Zhengzhou University, China. The hospital has a total capacity of 7000 beds out of which the cardiovascular ward constitutes 400 beds. Annually, an average of 40,000 patients with CAD comes to the hospital for seeking help out of which an average of 4000 patients undergo PCI.
Study design
The study was an institution based cohort study. The type of the study is prospective controlled study. The study took place between May 1, 2013-April 30, 2014. All patients with cardiovascular disease who came to the hospital during the data collection period were screened.
Selection of participants
A total of 60 consented patients with ST elevation myocardial infarction who had undergone PCI were included in the study by convenient method. At the baseline 30 of the patients (control group) had normal RDW while the remaining 30 patients (risk group) had a high RDW.
Inclusion criteria
Patients with ST elevation Myocardial infarction; having RDW 11-13.9% (normal RDW) were included in the control group and RDW ≥14% (high RDW) were included in the risk group.
Exclusion criteria
Patients with previous PCI or previous coronary bypass grafting and those with active inflammation and fever were excluded from the study.
Variables
Independent variables
Age, Sex, lipid profile, RDW, CK MB, Troponin, BNP, smoking status, diabetes mellitus, hypertension.
Dependent variables
Major Adverse Cardiac Events (Myocardial re-infarction, heart failure, arrhythmias, death, readmission), no Major Adverse Cardiac Event.
Operational definitions
1.
Red cell distribution width -a measure of the variability in the size of red blood cells. STEMI -A patient with myocardial infarction whose ECG showed an elevation of the ST-segment 2.
Elevated cardiac biomarkers -a patient with myocardial infarction whose troponin and/or CK-MB is elevated above the normal range 3.
Major adverse cardiac events -A patient with ST elevation myocardial infarction who underwent PCI and developed adverse events which include: arrhythmias, re-infarction, heart failure, re-admission, and/ or death.
Data collection tools
A questionnaire was prepared to document the necessary information including socio-demographic characteristics, baseline RDW, cardiac biomarkers (troponin, CK-MB), total cholesterol, low density lipoprotein cholesterol, triglycerides, high density lipoprotein cholesterol and outcome variables. The two groups of patients were followed for one month after undergoing PCI and their outcome recorded. Socio-demographic characteristics were obtained from the medical records of patients.
Laboratory procedures used for the data collection process RDW was measured through automated hematology analyzers and cardiac biomarkers (CK MB, troponin) were assessed using a chemiluminescent immune-enzymatic assay (Access AccuTnI, Beckman Coulter, Fullerton, CA, USA) and the detection limit of this assay is 0.01 ng/ml and the 99th percentile in the reference population is reported to be 0.04 ng/ml. Other tests used included fibrinogen, hsCRP and lipid profile. Coronary angiography was performed by percutaneous Trans-radial approach. Femoral approach was used for those patients in whom the Radial approach was difficult. The images were recorded digitally and all angiograms were analyzed by experienced cardiologist. Luminal narrowing of 75% or more for left anterior descending, left circumflex or right coronary artery and 50% or more for left main coronary artery was considered significant lesion.
Statistical analysis
Data analysis was performed using SPSS version 20 statistical software. Categorical data were expressed as proportions and continuous or numerical data were expressed as mean ± SD. Means of continuous variables between different categories were compared using t-test and chi-square test was used to compare proportions between both groups. Pearson's correlation coefficient was used to assess the strength of association between two continuous variables. Kaplan Meier Survival Analysis was used to detect the survival relationship between one month follow up and RDW Value. Bivariate logistic regression was used to control for confounding among the categorical variables and linear regression was used to control for confounding among the continuous variables. All statistical tests were based on a two tailed model and P-value <0.05 was considered a statistically significant finding.
Results
A total of 60 patients who were diagnosed to have ST elevation Myocardial infarction for whom PCI would be performed were included in the study. Before the procedure, they were classified into those with high RDW and those with normal RDW. The mean age among patients with high red cell distribution width was 65.8 ±11.1 years and among patients with normal RDW was 59.6± 9.9years. There was statistically significant difference between the means of ages in the two groups (t-test = 2.261, p-value = 0.028). The age for the high RDW ranged between 39 to 81 years and for the normal RDW, the age range was between 33 and 81 years. With regard to sex, the majority, 38 (63.3%), of the study participants were males and the rest, 22 (36.7%), were females. The socio-demographic distribution of patients was described in Table 1 .
The result showed that the height of the patients range between 1.4 and 1.8 meters (mean = 1.65 meter, SD = 0.07 meter). The mean weight of the patients was 68.3 kilogram (Range = 43 -88, SD = 11.3 Kg). With regard to BMI, the mean finding was 25.1 with SD = 3.6. The findings of baseline laboratory investigations were determined especially for CK-MB, troponin, BNP, total cholesterol, triglyceride, High density lipoprotein cholesterol, low density lipoprotein cholesterol and fibrinogen ( Table  2) .
In this study, older people had higher RDW value (p=0.028 r=0.028). There was no statistically significant difference between RDW and sex (P>0.05). Moreover, higher RDW patients had a higher fibrinogen level (p=0.026 r=0.024). Increased RDW group had both higher MACE events (p=0.09 r=0.33) and higher GRACE score (p= 0.025 r=0.024). Furthermore, patients with higher absolute RDW value had both higher GRACE (p= 0.01 r=0.427) and MACE (P= 0.000 r =0.5). In Kaplan Meier analysis normal RDW patients had better survival than higher RDW (Figure 1, Figure 2 , Table 3 and Table 4 ).
Death, readmission and arrhythmia were the major adverse cardiac events that were found in this study. One patient died, two patients readmitted due to heart failure and three patients developed arrhythmia during the one month follow-up period, all of whom were among the high RDW group. There was a statistically significant association between high RDW and the occurrence of major adverse cardiac event (X 2 = 6.67, P = 0.024). The result also showed that red blood cell distribution width (RDW) was the only factor which was associated with major adverse cardiac events (Table 5) .
Discussion
The present study demonstrated that out of the 60 ST elevation myocardial infarction patients included in the study, baseline red cell distribution width has a significant association with major adverse cardiac events after percutaneous coronary intervention (PCI). Ten percent of the whole study participants had MACE all of whom (100%) were from a high RDW group.
The underlying mechanism by which high levels of RDW are associated with STEMI is unclear, but believed to be due to increased inflammatory state, which has an important role in atherosclerosis (7). Inflammatory cytokines which are activated in STEMI have been found to suppress the erythrocyte maturation, so juvenile erythrocytes enter into circulation (8) . Also elevated levels of neuro-hormonal mediators stimulate erythropoiesis with a direct stimulation (9) . In addition, level of erythropoietin increases independent of hemoglobin levels and adrenergic activation may act on bone marrow response in patients with STEMI (10) .
Several studies evaluated a relation between increased RDW and morbidity and mortality of coronary artery disease. Ertekin et al, (4) showed that higher RDW values are associated with early adverse events following Coronary Artery Bypass Surgery (CABG). Mean RDW value for the whole study population was significantly higher in the adverse events. This was a consistent finding with the present study. A study done by Yan Borne et al, (11) which was a large population based cohort study, demonstrated that RDW had a graded independent association with risk of first hospitalization due to heart failure among middle-aged subjects. Another study by Azab et al, (12) showed that RDW is related to the prognosis of acute vascular conditions. Higher RDW was a strong and independent predictor of in-hospital and long term mortality in patients with non-STEMI. This finding also coincides with our finding although our study focuses among patients who undergo PCI. Uyarel et al, (13) reported that in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI, a high RDW level upon admission was associated with an increased risk for in-hospital and long-term cardiovascular events and mortality. This was also a similar finding with our study. Similarly, Turgay et al, (14) demonstrated that the baseline RDW level was found to be an independent predictor of the 6-month cardiovascular mortality after primary PCI. A study done by E. Cavusoglu et al, (15) showed that Table 5 . Linear regression between major adverse cardiac events and the different continuous variables.
RDW: Red-cell distribution width. RDW was a strong and independent predictor of mortality among an unselected population of males referred for coronary angiography. They also demonstrated that RDW was a powerful and independent predictor of mortality in the subpopulation of patients who had presented with acute coronary syndrome. Thus, our finding, although focusing among patients who underwent PCI, strengthens the previous studies done on RDW as predictor of the prognosis of patients with myocardial infarction who undergo different interventions. Considering the lower cost and its effectiveness, these findings suggest that RDW should not be undermined as an important and powerful tool in the management of patients with myocardial infarction who undergo different procedures. Our study also showed that RDW was the single most important predictor of outcome of patients undergoing PCI. The results have demonstrated that the other biomarkers didn't have significant correlation with major adverse cardiac events. Age of the patients was strongly correlated with an elevated baseline RDW, which means that RDW might be very helpful in patients with advanced age.
Our study has the following limitations; first, the follow-up period for patients' outcome was only one month and hence more cases of MACE that could have been found would be lost. Second, the study was not a large population-based cohort study. If it was so, the study would have been more powerful.
Conclusion and recommendations
Red cell distribution width is positively correlated with major adverse cardiac events (MACE) in STEMI patients undergoing percutaneous coronary intervention. It is also positively correlated with GRACE score and increasing age of patients.
Since RDW was the single most useful predictor of major adverse cardiac events in STEMI patients undergoing PCI and because of the low cost of the test, we strongly recommend that it should be routinely used as a baseline test in the management of patients with ST elevation myocardial infarction undergoing percutaneous intervention.
Furthermore, since physicians are not well familiar with the use of RDW in any clinical situations, great emphasis should be given to sensitize them so that they will routinely order RDW in any STEMI patient coming to the cardiac hospital.
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